International Cannabis Weekly: 424

GERMANY EXPANDS MEDICAL CANNABIS IMPORT CAP AS AUSTRALIA MOVES TO LIMIT SUPPLY

Australia and Germany are moving in opposite directions on medical cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets. This week, Australia’s Office of Drug Control (ODC) confirmed that the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board (INCB) from 101 tonnes to 88 tonnes, following chronic over-forecasting and unused permits that locked up capacity.

READ MORE  »

WHY CPD-CERTIFICATION MATTERS FOR MEDICAL CANNABIS CLINICIANS

READ MORE »

THE BATTLE OVER HEMP HEATS UP AS LAWMAKERS AND INDUSTRY CLASH

READ MORE »

• German cultivation clubs are facing collapse under the country’s strict regulations.
• Belvedere Pharma removed from Infarmed’s list of licensed cannabis entities.
• Volt Cyprus proposes cannabis legalisation to boost jobs and state revenue.
• Early results from Züri Can pilot bolster case for Switzerland’s federal legalisation.
• Avextra enrols first patient in landmark Italian trial of cannabis-based medicine.
• How cannabis interacts with pain, sleep & anxiety.

GET TICKETS NOW »

• Michigan hemp farmers face rising costs as state fails to withdraw from federal program.
• Omaha Tribe of Nebraska holds meeting to finalise cannabis commission framework.
• New York cannabis retailers push back against $30m recall and licensing scandal.
• Nebraska tribe has issued the first cannabis licence amid state rollback of medical law.
• A Nebraska mother continues campaign for medical cannabis to treat son’s epilepsy.
• Culta has named the industry veteran Joseph Andreae as its new chief executive officer.
• New Hampshire lawmakers have approved a new bill to legalise adult-use cannabis.
• Poll shows strong Kansas support for medical and recreational cannabis reform.

• Boston Beer Company launches Emerald Hour cannabis gummies in Canadian market.
• A new survey finds Canadians see cannabis as mainstream and want industry growth.
• Ontario’s retail cannabis market faces oversaturation as stores struggle to survive.
• Ayurcann reports record $55.4 million in annual cannabis revenue, up 21% year-on-year.
• British Columbia resumes cannabis operations following tentative end to strike action.
• Auxly has repaid approximately $5 million inventory loan as part of debt reduction plan.
• High Tide is poised to open new Canna Cabana retail location in Hamilton, Ontario.
• Aurora Cannabis is set to host Q2 2026 investor conference call for its shareholders.

WATCH NOW »

• Brazil’s leading medical cannabis fair has been evolved with new identity and vision.
• Colombian firms are seeking to simplify their cannabis export processes to Brazilian market.
• Cookies has launched a premium wellness and lifestyle cannabis brand in Brazil.
• Colombia’s president urges Donald Trump to legalise cannabis to curb illicit trade.

• Vanuatu debates long-delayed reform to unlock hemp and medical cannabis sectors.
• New Zealand Greens renew call for evidence-based cannabis regulation approach.
• South Korean researchers explore cannabis compounds in advanced medical study.
• NAB has agreed to write off approximately $54 million in the Cann Group debt restructuring deal.

• IM Cannabis has signed signed an agreement to acquire 60% stake in Quantum Innovations.
• Morocco began exporting first batches of cannabis-based medicine abroad.
• Labat exits cannabis industry, selling CannAfrica and non-core assets for R23 million.
• Intercure reports strong half-year results as Botanico acquisition advances.